With emphasis on biotechnology, Trevor focuses his portfolio on undervalued micro and small-cap companies. As a contributor to TalkMarkets, he hopes to elucidate undervalued companies that are exploring revolutionary treatment modalities for a wide spectrum of rare and devastating medical ...more

With emphasis on biotechnology, Trevor focuses his portfolio on undervalued micro and small-cap companies. As a contributor to TalkMarkets, he hopes to elucidate undervalued companies that are exploring revolutionary treatment modalities for a wide spectrum of rare and devastating medical conditions. Trevor strives for an open, honest and insightful dialogue with expert and amateur readers alike. He appreciates your comments and encourages readers to follow him and stay updated on his newest stock ideas.less